NCT00050713View on ClinicalTrials.gov

Sirolimus Therapy for Idiopathic and Lupus Membranous Nephropathy

PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

December 17, 2002

Primary Completion Date

August 27, 2007

Study Completion Date

August 27, 2007

Conditions
Membranous GlomerulonephritisLupus Membranous Nepropathy
Interventions
DRUG

Sirolimus

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

NCT00050713 - Sirolimus Therapy for Idiopathic and Lupus Membranous Nephropathy | Biotech Hunter | Biotech Hunter